You are viewing the site in preview mode

Skip to content

Advertisement

  • Review
  • Open Access

Schwannoma of the colon and rectum: a systematic literature review

World Journal of Surgical Oncology201816:125

https://doi.org/10.1186/s12957-018-1427-1

  • Received: 5 March 2018
  • Accepted: 22 June 2018
  • Published:

Abstract

Background

Schwannomas of the colon and rectum are rare among gastrointestinal schwannomas. They are usually discovered incidentally as a submucosal mass on routine colonoscopy and diagnosed on pathologic examination of the operative specimen. Little information exists on the diagnosis and management of this rare entity.

The aim of this study is to report a case of cecal schwannoma and the results of a systematic review of colorectal schwannoma in the literature.

Main body

PubMed, Scopus, and Cochrane database searches were performed for case reports and case series of colonic and rectal schwannoma.

Ninety-five patients with colonic or rectal schwannoma from 70 articles were included. Median age was 61.5 years (59% female). Presentation was asymptomatic (28%), rectorrhagia (23.2%), or abdominal pain (15.8%). Schwannoma occurred in the left and sigmoid colon in 36.8%, in the cecum and right colon in 30.5%, and in the rectum in 21.1%. Median tumor size was 3 cm and 56.2% of patients who underwent preoperative colonoscopy had a typical smooth submucosal mass. At pathology, 97.9, 13.7, and 5.3% of schwannomas stained positive for S100, vimentin, and GFAP, respectively. The median mitotic index was 1/50.

Conclusions

Colorectal schwannoma is a very rare subtype of gastrointestinal schwannoma which occurs in the elderly, almost equally in men and women. Schwannoma should be included in the differential diagnosis of a submucosal lesion along with gastrointestinal stromal tumor, neuro-endocrine tumors, and leiomyoma-leiomyosarcoma. Definitive diagnosis is based on immunohistochemistry of the operative specimen. Rarely malignant, surgery is the mainstay of treatment.

Keywords

  • Schwannoma
  • Colon
  • Rectum
  • Review
  • Diagnosis
  • Treatment

Background

Schwannomas of the gastrointestinal tract are spindle cell tumors originating from peripheral nerve lining Schwann cells and represent a very rare entity, accounting for approximately 2–6% of all mesenchymal tumors [1, 2]. In fact, the differential diagnosis of this entity includes all mesenchymal or neuro-ectodermal neoplasms, in decreasing frequency: gastrointestinal stromal tumors (GISTs), leiomyomas, leiomyosarcomas, neurofibromas, ganglioneuromas, paragangliomas, lipomas, granular cell tumors, and glomus tumors [3]. Gastrointestinal tract schwannomas occur in decreasing frequency in the stomach (83%), small bowel (12%), and, finally, the colon and rectum [1]. Gastrointestinal schwannomas occur at similar rates in men and women with a mean age of 60–65 years [3]. Most commonly, schwannoma is discovered incidentally on screening endoscopy or during abdominal imaging that is being done for another reason, and the diagnosis is made on definitive pathologic examination of operative specimen [4]. On immunohistology, they stain positive for S100. Gastrointestinal schwannomas occur indifferently in men and women with a mean age of 60–65 years [3]. Rectal schwannoma may cause symptoms such as obstruction, bleeding, and tenesmus. Few data exist on this rare entity in the literature.

The aim of this study is to report an incidental finding cecal schwannoma with a systematic literature review of colorectal schwannoma, to describe the clinical, diagnostic (endoscopic, abdominal imaging), pathologic, and prognostic features of colorectal schwannomas.

Materials and methods

We performed a systematic review of the literature using three databases (PubMed, Scopus, and Cochrane). In the PubMed search, we used the following search terms: (“Colorectal Neoplasms”[Mesh]) AND “Neurilemmoma”[Mesh] with filter for case reports and (“Colorectal Neoplasms”[Mesh]) AND “Neurilemmoma”[Mesh] AND case series. Free terms included (colorectal OR rectum OR rectal OR colon OR colonic) AND Schwannoma and (colorectal OR rectum OR rectal OR colon OR colonic) AND Schwannoma AND case series. In the Scopus database search, we used the terms (TITLE-ABS-KEY ({case report})) AND (TITLE-ABS-KEY(schwannoma) AND TITLE-ABS-KEY(colorectal OR rectum OR rectal OR colon OR colonic)) OR ((TITLE-ABS-KEY(schwannoma) AND TITLE-ABS-KEY(colorectal OR rectum OR rectal OR colon OR colonic)) AND ({case series})). In the Cochrane search, we used the following: Title-abstract-keywords: Schwannoma and Title-abstract-keywords: Neurilemmoma. The search strategy had no publication date, or publication type restriction. In addition, the reference lists of relevant reviews or included articles were also searched to find other eligible studies. We included only studies published in English.

Study characteristics such as patient age, sex, and presenting symptoms, diagnostic exams, tumor characteristics (size, location, appearance on colonoscopy and on imaging), timing of diagnosis (endoscopic biopsy or post-operatively), type of resection (endoscopic, transanal, laparoscopic, and open), tumor immunostaining (S100, vimentin, glial fibrillary acidic protein [GFAP], Ki67), and mitotic rate reported in the pathology report, lymph node status, and the degree of aggressiveness of the tumor were evaluated in the literature review.

Results

Case report

An asymptomatic 70-year-old female known to have surgically treated squamous cell carcinoma of the nose underwent a routine screening colonoscopy that revealed an uncomplicated diverticulosis and a cecal submucosal mass (Fig. 1). The appearance was most likely correlated with a submucosal tumor and less likely to be an extrinsic compression. At pathology, colonoscopic biopsies of the mass showed normal colonic mucosa. Laboratory examination showed no anemia (hb 13.2 g/dL) was negative for CEA tumor marker (CEA 2.2 μg/L). Abdominal computed tomography scan (CT scan) revealed a well-circumscribed hypervascular anterior cecal wall mass (Fig. 2) with no liver metastases and no other distant lesions. The mass had no metabolic activity on either FDG-PET scan or on Octreo-PET (Fig. 3a, b).
Fig. 1
Fig. 1

Colonoscopic view of the anterior submucosal mass

Fig. 2
Fig. 2

CT scan (axial) showing the hypervascular well-circumscribed cecal mass

Fig. 3
Fig. 3

a Absence of metabolic activity on Octreo-PET/CT (axial). b Corresponding image on CT scan

After multidisciplinary team discussion, a differential diagnosis of mesenchymal tumor of the colon (GIST, leiomyoma, and leiomyosarcoma) was suggested and we decided to perform an exploratory surgery. The patient was consented for open exploration by mini-laparotomy and possible right hemi-colectomy. The right colon was mobilized at the white line of Toldt, the 3 cm white cecal mass was well circumscribed, and a wedge resection, including the appendix, using GIA 75 (Ethicon Endo-Surgery GIA; 75 mm; Guaynabo, Puerto Rico 00969 USA) was performed. The operative specimen was sent for frozen section at pathology. The temporary diagnosis was a benign spindle cell tumor. The intra-operative decision was to wait for the definitive histopathologic examination report in order to try to avoid a right hemicolectomy. The final pathology report revealed a benign spindle cell tumor that stained negative for CD117 and DOG-1 and was diagnosed as cecal schwannoma with a reactive lymph node (Fig. 4).
Fig. 4
Fig. 4

a Hematoxylin eosin (HE) staining showing the spindle cell type tumor. b Absence of tumor immunohistochemistry (IHC) staining for CD117. c Tumor IHC staining for S100

The post-operative course was uneventful and the patient started oral feeding the same night and was discharged on day 5 with pain killers. The final multidisciplinary committee decision was follow-up without further treatment needed. At 1-year follow-up, the patient is disease free.

Systematic literature review

Study selection

A total of 521 articles were identified from the PubMed, Scopus, and Cochrane databases. After removing duplicated articles, 230 articles remained for further assessment. A total of 171 articles were excluded on the basis of the titles and the abstracts. Of the remaining 120 articles, only 78 articles had full text published in English. After full text review of these remaining articles, 70 were eligible and included in the systematic review (Fig. 5).
Fig. 5
Fig. 5

PRISMA flowchart summarizing the process for the identification of eligible studies

Patient and tumor characteristics

A total of 70 articles (Table 1) reporting 95 cases of colorectal schwannoma were found, including one article reporting a series of 20 colorectal schwannomas from the Armed Forces Institute of Pathology [4]. A total of 96 patients were reviewed, including our case [1, 2, 471]. The statistical analysis of all patient characteristics is listed in Table 2.
Table 1

Schwannomas of the colon and rectum: clinical and histopathologic characteristics of published case reports

Study

Age

G

Symptoms

S

Location

Colonoscopy and imaging

Diagnosis

Surgery/LN

(Antonini) S-100 +/mitosis

Tsunoda [1]

67

F

FOB

3

Transverse

Ulcerated S-M/ CT: well circumscribed, homogenous enhancement, EUS: hypo-echoic S-M

Post-Sur

Open/−

NSE/MIB-1 low

Nonose [2]

71

F

Tenesmus

3

Sigmoid

Ulcerated S-polyp

Biopsy

Lap/−

(A)Ki67 < 5%

Miettinem [4]

20

82

M

NA

0.5

Rectum

S-M/NA

Biopsy

Endoscopy/NA

Mitosis 0/50

30

F

FOB

1.5

Sigmoid

S-M/NA

Biopsy

Endoscopy/NA

Mitosis 2/50

83

M

NA

2.3

Cecum

NA

Post-Sur

Open/NA

Mitosis 1/50

64

F

Asymptomatic

2.5

Transverse

NA

Post-Sur

Open/NA

Mitosis 1/50

62

M

Rectorrhagia

2.5

Left

NA

Post-Sur

Open/NA

Mitosis 0/50

65

M

Asymptomatic

2.8

Cecum

Cecal mass/NA

Post-Sur

Open/NA

Mitosis 0/50

80

F

NA

3

Sigmoid

S-polyp/NA

Post-Sur

Open/NA

Mitosis 1/50

71

F

Rectorrhagia

3

Cecum

NA

Post-Sur

Open/NA

Mitosis 0/50

58

M

Rectorrhagia

3

Transverse

NA

Biopsy

Open/NA

Mitosis 0/50

57

F

Rectorrhagia

3

Sigmoid

S-M/NA

Post-Sur

Open/NA

Mitosis 1/50

84

F

Asymptomatic

3.9

Cecum

NA

Biopsy

Openb/NA

Mitosis 0/50

87

M

NA

4

NA

NA

Post-Sur

NA

Mitosis 5/50

75

F

Constipation

4

Transverse

S-M/NA

Post-Sur

Open/NA

Mitosis 1/50

18

F

Intussusception

5

Cecum

S-M/NA

Post-Sur

Open/NA

Mitosis 3/50

72

M

NA

5.5

Cecum

S-M/NA

Post-Sur

Open/NA

Mitosis 0/50

55

M

NA

0.7

Sigmoid

S-M/NA

Post-Sur

Open/NA

Mitosis 0/50

58

F

NA

0.8

Sigmoid

NA

Post-Sur

Open/NA

Mitosis 0/50

72

M

Weight lossa

1

Sigmoid

S-polyp/NA

Biopsy

Endoscopy/NA

Mitosis 0/50

61

F

Ulcer symptoms

5

Sigmoid

NA

Post-Sur

Open/NA

Mitosis 0/50

23

F

Asymptomatic

5.5

Sigmoid

NA

Post-Sur

Open/NA

Mitosis 1/50

Barbeiro [5]

49

F

Asymptomatic

3

Right

S-M/CT: well circumscribed, homogenous enhancement

Post-Sur

Open/−

Low mitosis

Jung [6]

59

F

Rectorrhagia

4.8

Sigmoid

Fungating mass/CT: enlarged LN, FDG-PET: Hyper

Post-Sur

Open/−

Mitosis < 1/10

Park [7]

2

52

F

NA

1.3

Right

S-M/CT: well circumscribed, homogenous enhancement

Post-Sur

Lap/NA

NA

59

F

Asymptomatic

1.5

Left

S-M/CT: well circumscribed

Post-Sur

Lap/NA

NA

Hornick [8]

48

M

NA

5

NA

NA

NA

NA

NA

Akgul [9]

57

F

Tenesmus

6.5

Rectum

S-M/ CT: isodense + central necrosis

Post-Sur

Open/NA

NA

Wang [10]

62

F

Rectorrhagiaa

4

Right

S-polyp/CT: well circumscribed, homogenous low enhancement

Post-Sur

Open/NA

(A) Ki-67 < 3%

Tashiro [11]

64

F

Asymptomatic

5

Right

S-M/CT: well circumscribed, homogenous enhancement

Post-Sur

Lap/−

MIB-1 < 5%

Suzuki [12]

70

F

Asymptomatic

18

Rectum

S-M/ MRI: hypo T1- hyper T2, EUS: hypo-echoic S-M

Post-Sur

Transanal μ/NA

< 1/10

Bugiantella [13]

65

M

FOB

2.5

Sigmoid

S-M/ EUS: hypo-echoic S-M

Post-Sur

Lap/−

Vimentin/Ki-67 < 2%

De Mesquita [14]

79

F

Weight lossa

10

Cecum

NA/CT: well circumscribed, homogenous low enhancement

Post-Sur

Open/NA

Vimentin/NA

Vasilakaki [15]

68

M

Rectorrhagia

4

Right

S-M/NA

Post-Sur

Open/−

NA

Kanneganti [16]

35

F

Melenaa

4

Cecum

Ulcerated S-M/CT: mass

Post-Sur

Open/NA

low

Goh [17]

2

54

F

Abdominal pain

3

Right

Obstructing mass/NA

Post-Sur

Open/NA

NA

41

F

Rectorrhagia

2.9

Rectum

S-M/EUS: S-M

Post-Sur

Transanal/NA

NA

Inagawa [18]

2

73

F

Rectorrhagiaa

3.5

Sigmoid

Hard ulcerated S-M/CT: high density

Post-Sur

Open/NA

(A)vimentin, GFAP/NA

44

M

FOB

1

Cecum

S-M/NA

Biopsy

Endoscopy/NA

(A) vimentin, GFAP/NA

Turaihi [19]

61

F

Rectorrhagia

4

Cecum

S-M/CT: mass

Post-Sur

Lap/−

NA

Uhr [20]

73

F

Asymptomatic

3.1

Left

S-M/CT: mass + enlarged LN

Post-Sur

Lap/NA

(A)NA

Meeks [21]

95

F

Obstruction

1

Appendix

NA

Post-Sur

Open/NA

NA

Terada [22]

52

M

Asymptomatic

0.9

NA

S-M

Biopsy

Endoscopy/NA

NA

Çakir [23]

79

F

Rectorrhagia

5

Sigmoid

Rough ulcerated mass/CT: ulcerated mass

Post-Sur

Open/−

Vimentin/Ki-67 < 5%

Dickson [24]

72

M

Rectorrhagiaa

 

Cecum

S-M/CT: mass

Post-Sur

Open/NA

(A, B) NA

Tokuhara [25]

74

F

FOB

3

Sigmoid

S-M/EUS: hypo-echoic S-M

Post-Sur

Lap/NA

(A)MIB-1 < 3%

Baskaran [26]

49

M

FOB

 

Pancolic

S-M/NA

Biopsy

Endoscopy/NA

NA

Verdu-Fernandez [27]

67

M

Asymptomatic

4.5

Left

NA/CT: mass with enlarged LN, US: intussusception

Post-Sur

Open/NA

CD68

Baek [28]

70

F

Asymptomatic

2

Cecum

Polyp/CT: polyp with low attenuation

Post-Sur

Lap/NA

(A) CD34/ Ki-67 < 5%

Petrie [29]

25

M

Bloody diarrheaa

4

Sigmoid

Friable mucosa/CT: obstructing mass

Post-Sur

Open/NA

(A)NA

Shelat [30]

63

F

Anorexiaa

 

Rectum

S-polyp/CT: polyp

Post-Sur

Open/−

NA

Trivedi [31]

61

M

NA

1.3

Sigmoid

S-polyp/NA

Post-Sur

Endoscopy/NA

CD34/MIB-1 < 2%

Kawaguchi [32]

77

F

Tenesmus

1

Rectum

S-M/EUS: hypoechoic, CT: mass

Biopsy

Endoscopy/NA

(A) mitosis < 1/10

Tan [33]

63

F

Early satiety

3

Rectum

S-polyp/MRI: mass

Post-Sur

Open/ NA

NA

Yang [34]

2

27

F

Rectorrhagia

3

Rectum

S-M/NA

Post-Sur

NA

NA

53

M

Asymptomatic

2

Sigmoid

S-M/NA

Post-Sur

NA

NA

Matsumoto [35]

59

F

Asymptomatic

2

Cecum

S-M/CT: well circumscribed, homogenous enhancement

Post-Sur

Lap wedge/NA

Vimentin/ MIB-1 < 2%

Kim [36]

61

M

Asymptomatic

1.8

Right

Polypoid/CT: well circumscribed, homogenous enhancement

Biopsy

Lap/NA

NA

Vijayasekaran [37]

75

F

Asymptomatic

3.2

Rectum

NA/EUS: S-M, CT: enlarged LN

Post-Sur

Open

NA

Wu [38]

84

M

NA

 

Rectum

NA: FDG PET: hyper

Post-Sur

NA

NA

Tedeschi [39]

80

M

Rectorragia

4

Rectum

S-polyp/CT: mass

Post-Sur

Open/NA

(A)mitosis < 1/10

Tanaka [40]

70

F

FOB

 

Left

Ulcerated S-M/CT: well circumscribed, homogenous enhancement

Post-Sur

Open/NA

(A,B)NA

Rocco [41]

67

F

Asymptomatic

0.3

Left

S-polyp/NA

Biopsy

Endoscopy/NA

NA

Wani [42]

75

F

Abdominal pain

5

Right

S-polyp/NA

Post-Sur

Open/NA

NA

Kienemud [43]

2

70

F

Asymptomatic

0.7

Sigmoid

S-M/NA

Post-Sur

Open/NA

(B)NA

70

M

Asymptomatic

1.3

Sigmoid

S-polyp/NA

Biopsy

Endoscopy/NA

(B)NA

Hsu KF [44]

88

F

Constipation

3.5

Rectum

S-M/EUS: hypoechoic, CT: no enlarged LN

Post-Sur

Transanal/NA

(A,B)NA

Wilde [45]

68

F

Explosive diarrhea,

1.5

Sigmoid

NA

Post-Sur

Open/−

(B)vimentin, GFAP/NA

Mysorekar [46]

33

M

Abdominal pain

3.5

Right

S-polyp

Post-Sur

Endoscopy/NA

(A,B)NA

Lee [47]

32

F

Constipation

1.4

Right

S-polyp

Biopsy

Endoscopy/NA

NA

Chetty [48]

43

F

Asymptomatic

 

NA

S-polyp

Biopsy

Endoscopy/NA

HMB-45, Melan-A/NA

Brauman [49]

55

M

Constipation

5

Right

S-polyp/CT: mass with enlarged LN

Post-Sur

Open/NA

Β-catenin, CD117/MIB-1 < 5%

Zippi [50]

72

M

Abdominal pain

1.5

Rectum

S-M/NA

Biopsy

Endoscopy/NA

(A,B) NA

Hsu CT [51]

68

M

Abdominal pain

3.5

Left

S-M/ CT: well circumscribed, low homogenous enhancement,

Post-Sur

Open/NA

NA

Emanuel [52]

48

M

Rectorrhagia

4.9

Left

Obstructing mass/CT: intussusception

Post-Sur

Open/NA

(A)EMA, CD34, vimentin/NA

Fotiadis [53]

55

M

Rectorrhagia

 

Sigmoid

S-M/CT: no metastasis

Post-Sur

Open/NA

(B)NA

Bhardwaj [54]

35

F

Tenesmus

2.3

Rectum

Mass/NA

Post-Sur

Open/NA

(A)GFAP/NA

Jacobson [55]

56

F

Asymptomatic

1.7

Sigmoid

S-M/NA

Post-Sur

Open/NA

(A)mitosis < 1/10

Maciejewski [56]

67

F

Abdominal pain

8

Rectum

S-M/US: large exophytic mass

Post-Sur

Open wedge/NA

(A)vimentin/NA

Matsushita [57]

79

M

NA

 

Transverse

S-M

Biopsy

Endoscopy/NA

NA

Horio [58]

66

M

FOB

3

Sigmoid

S-M

Post-Sur

Open/NA

Vimentin/NA

Sasatomi [59]

68

F

Rectorrhagia

4.7

Sigmoid

S-M/CT: mass

Post-Sur

Open/−

NA

Prévot [60]

74

M

NA

2

Right

NA

Post-Sur

Open/NA

Vimentin, NSE/NA

Tomozawa [61]

66

M

Asymptomatic

3.5

Right

Polypoid mass/CT: no enlarged LN

Biopsy

Open/NA

(A,B)vimentin/mitosis < 1/80

Skopelitou [62]

69

F

Rectorrhagia

3.5

Left

Polypoid mass/barium enema: obstruction

NA

Open/NA

GFAP, leu7/mitosis < 3/10

Kakizoe [63]

72

M

Asymptomatic

1.5

Rectum

S-M/NA

Post-Sur

Transanal μ/NA

(A)NA

Murakami [64]

75

M

Asymptomatic

2.2

Rectum

Ulcerated S-M/NA

Biopsy

Transanal/NA

NA

Sugimura [65]

14

M

Melena

 

Sigmoid

NA/barium enema: mass, CT: mass of soft tissue

Post-Sur

Open/NA

(A)vimentin/NA

Abe [66]

2

52

M

Protruding mass

1.5

Rectum

S-M

Biopsy

Transanal/NA

(A)NA

52

F

Rectal discomfort

4.5

Rectum

Polyp

Biopsy

Transanal/NA

(B)NA

Schwartz [67]

18

F

Abdominal girth

28

Sigmoid

NA

Post-Sur

Open/NA

(A)NA (malignant)

Cleveland [68]

60

F

Abdominal girth

20

Transverse

NA/abdominal X-ray: large mass aortogram

Post-Sur

Open/NA

NA

Bodner [69]

63

F

Constipation

 

Rectum

Recurrence, malignant transformation

Biopsy

Abdominal

Malignant

Wang CL [70]

77

F

NA

2.4

Cecum

NA/CT: well circumscribed, low homogenous enhancement FDG PET: hyper

Biopsy

Open/NA

(A,B)NA

Catania [71]

41

M

Tenesmus

8

Rectum

NA/heterogenous large mass

Post-surg

Open/−

c-Kit/NA Malignant

Present case

70

F

Asymptomatic

2

Cecum

S-M/CT: well circumscribed, homogenous enhancement, FDG PET: hypo, Octreo PET: hypo

Post-Sur

Openwedge/−

< 1/10

S-M submucosal mass, S-polyp submucosal polyp, NA not available, − negative

aAssociated with abdominal pain

bEnucleation

Table 2

Patient characteristics

Characteristics

Number

95

Age

61.2 years, range 14–95, median 64 years

Sex

 Male

40 (41.7%)

 Female

56 (58.3%)

Presenting symptom

 Asymptomatic

27 (28.1%)

 Rectal bleeding

22 (22.9%)

 Fecal occult blood

8 (8.3%)

 Abdominal pain

15 (15.6%)

 Constipation

7 (7.3%)

 Tenesmus

7 (7.3%)

Abdominal girth

2 (2.1%)

 NA

14 (14.6%)

Location

 Cecum and right colon

29 (30.2%)

 Transverse colon

5 (5.2%)

 Sigmoid

27 (28.1%)

 Left colon

8 (8.3%)

 Rectum

21 (21.9%)

 Appendix

1 (1%)

 NS

5 (5.2%)

Colonoscopy

73 (76%)

 Smooth submucosal mass

41 (56.2%)

 Ulcerated submucosal mass

5 (6.8%)

 Submucosal polyp

15 (20.5%)

 Intraluminal mass

6 (8.2%)

 Polypoid

3 (4.1%)

 Others

3 (4.1%)

Imaging

46 (48%)

 CT-SCAN

35 (76%)

  Well circumscribed

13 (37.1%)

  Homogenous enhancement

12 (34.3%)

  Central necrosis

1 (1%)

 EUS: hypo-echoic mass

7 (7.3%)

 FDG-PET

4 (4.2%)

 Hyper

3 (3.1%)

 Size (cm)

3.78 cm, range 0.3–28, median 3 cm

Diagnosis

 Endoscopy

23 (24%)

 Post-surgery

71 (74%)

Type of surgery

 Laparoscopic

11 (11.5%)

 Open

58 (60.4%)

 Endoscopic

15 (15.6%)

 Transanal

7 (7.3%)

 NA

5 (5.2%)

Extent of surgery

 Classical segmental

65 (67.7%)

 Wedge

3 (3.1%)

 Endo-luminal

23 (24%)

Tumor markers

 S100

94 (97.9%)

 Vimentin

13 (13.5%)

 GFAP

5 (5.2%)

 CD-34

2 (2.1%)

 CD-68

1 (1%)

Antonini type

26 (27.1%)

 A

15 (57.7%)

 B

6 (23.1%)

 A, B

5 (19.2%)

Mitosis

 Ki-67%

5 (5.2%)

 MIB-1

6 (6.3%)

 Low mitosis

30 (31.3%), mean 2.1/50, median 1/50

 NA

55 (57.3%)

LN

 NA

85 (88.5%)

 Negative

11 (11.5%)

Aggressiveness

 

 Benign

93 (96.9%)

 Malignant

3 (3.1%)

There were 40 male (41.7%) and 56 female (58.3%) patients with a mean age of 61.2 years (range 14 to 95 years). Thirty-five patients (36.4%) were asymptomatic at presentation, including eight with positive fecal occult blood test (8.3%). The most common presenting symptoms were rectorrhagia (22.9%) followed by nonspecific abdominal pain (15.6%), constipation (7.3%), tenesmus (7.3%), and increased abdominal girth (2.1%).

Schwannoma occurred most frequently in the cecum and right colon (30.5%) followed by the sigmoid (28.1%), the rectum (21.1%), the left colon (8.3%), the transverse colon (5.3%), and the appendix (1.1%). The tumor size ranged from 0.3 to 28 cm with a mean of 3.78 cm (median 3 cm).

On colonoscopy, results were available in 73 out of 96 patients (76%). Schwannoma had the typical submucosal mass appearance with smooth mucosal surface in 41 (56.2%) and with ulcerated mucosa in 5 (6.8%). Fifteen patients (20.5%) had a tumor described as submucosal polyp, and nine patient tumors (12.3%) were described as a mass, either fungating (8.2%) or polypoid (4.1%).

Pre-operative tumor imaging results were available for 46 patients (48%). The most common imaging done was abdominal CT scan (35 patients, 76%). In the majority, the CT scan report lacked a description of the schwannoma and identified a colorectal mass. In 12 cases (34.3%), the schwannoma was described as a well-circumscribed homogenous lesion with low enhancement on arterial phase and in one case as a well-circumscribed homogenous lesion without arterial phase enhancement. Endorectal ultrasound (EUS) results were available for only seven patients (7.3%) and all of these showed a transmural hypo-echogenic mass. FDG-PET/CT scan was done in only four patients (including our patient) and showed a hypermetabolic lesion in three of them.

The diagnosis of schwannoma was made on the operative specimen in the majority of patients (74%), on endoscopic or transanal biopsy in 23 patients (24%), and diagnostic method was not reported in 2% of cases.

All patients with no biopsy or inconclusive biopsies underwent radical colonic resection either open (60.4%) or laparoscopic (11.5%). Three patients were diagnosed with schwannoma pre-operatively and underwent wedge colonic resection. Fifteen patients had colonoscopic resection at their initial examination and resection was judged sufficient and they did not undergo further treatment. Transanal surgery was performed in seven patients with rectal schwannomas including two treated by transanal microsurgery.

On pathologic examination, the Antonini subtype was available or deduced in 26 out of 96 patients, 57.7% were type A (14 patients), half of the remaining were type B, and the other half were both types A and B. In all available immuno-histologic examinations, schwannomas stained positive for S100 in 97.9%, for vimentin in 13.5%, for glial fibrillary acidic protein (GFAP) in 5.2%, for CD34 in 2.1%, and for CD68 in 1%. Tumor mitotic activity results were reported in only 41 patients (Ki-67 in 5 patients (5.3%) the highest below 5%, MIB-1 in 6 patients (6.3%) the highest < 5%, and low mitotic count in 30 (31.6%) with a mean of 2.1/50 and a median of 1/50 high-power fields). Lymph node status was available in only 11 pathology reports (11.5%) and was negative in all of these. Schwannoma was judged to be benign in 93 out 95 patients (96.9%), and local and hepatic pattern recurrences were observed in 3 patients (3.1%) and were reported as “malignant” schwannomas [67, 69, 71].

Discussion

Schwannomas are extremely rare tumors of the nerve sheath, developing from Schwann cells. In the gastrointestinal tract, they present as spindle cell tumors, originating from Auerbach’s myenteric plexus rather than Meissner’s submucosal plexus, and account for approximately 2–6% of all mesenchymal tumors [1].

Colorectal schwannoma is a very rare neoplasm and is the least frequent location for a GI schwannoma [1, 2]. Based on our systematic review, colorectal schwannoma occurs slightly more in female patients (59%), with a mean age of 61.5 years, and a wide age range from 14 to 95 years. Schwannoma is frequently diagnosed as a submucosal mass or polyp [4, 10, 28, 30, 31, 33, 39, 4143, 4649, 66] with a smooth surface but in rare cases can ulcerate into the mucosa [1, 2, 16, 18, 23, 29, 40]. This submucosal mass is usually discovered incidentally during routine screening colonoscopy. As is true for all other mesenchymal tumors, mucosal biopsy is usually inconclusive. Deep biopsy or submucosal resection [4, 18, 22, 26, 31, 41, 43, 4648, 50, 57] can help differentiate schwannoma from other mesenchymal tumors such as gastrointestinal stromal tumors (GIST), neuro-endocrine tumors (NET), leiomyomas, and leiomyoma-sarcomas, or from adenocarcinomas in cases where the mucosa is ulcerated. In decreasing frequency, schwannoma occurs in the right colon and cecum, followed by the sigmoid colon, the rectum, the left colon, and, finally, the transverse colon. The size of schwannomas ranges from less than 1 cm lesions to very large tumors up to 28 cm that present with an increase in abdominal girth [67, 68].

For differential diagnosis of schwannoma, abdominal CT scan can help differentiate between schwannoma and other mesenchymal tumors. Schwannomas appear as well-defined homogenous mural masses with low enhancement [1, 5, 7, 10, 11, 14, 35, 36, 40, 51, 70] in comparison with the heterogenous aspect of GIST and the ill-defined aspect of adenocarcinomas [72]. Less than half of the published case reports had a CT scan done, approximately half of these had endoluminal resection and did not require abdominal imaging. In two thirds of patients who underwent CT scan, the published case reports lacked a description of the colorectal mass scan and did not specify the characteristics of the mass with regard to shape and arterial enhancement, factors which might be helpful for differential diagnosis. Echo-endoscopic ultrasonography can also be useful for diagnosis as schwannoma appears as a well-defined transmural hypoechoic mass.

In this review, four patients (4.16%) underwent metabolic imaging (FDG-PET/CT scan). Schwannoma exhibited hypermetabolic activity in three of these (75%) and no metabolic activity in one of them (25%). In the majority of cases, FDG-PET/CT scan was performed in the preoperative work-up of an atypical colorectal mass to differentiate between a malignant and a benign lesion, as in our case report. In patients with and without metabolic activity, all lesions were reported as benign. Although reported data are limited, current data do not suggest a role for FDG-PET/CT scan to differentiate between benign and malignant gastrointestinal schwannoma. In addition, octreotide receptor PET/CT scan can help to exclude the diagnosis of NET, as in the present report.

The definitive diagnosis is made on immunohistopathologic examination of the operative specimen. Macroscopically, schwannomas tend to be lobulated well-defined tumors ulcerating into the mucosa [73]. Furthermore, they stain positive for S100, and occasionally for vimentin, and stain negative for SMA, Desmin, CD117, and P53 [74]. One of the malignant schwannomas [71] had a c-kit mutation along with S100 which makes a diagnosis of GIST more likely, although the tumor was considered to be a malignant schwannoma.

Two histological growth patterns have been described: Antoni A, characterized by the dense growth of fusiform cells compactly arranged in palisades to form Verocay bodies and Antoni B in which the fusiform cells are more loosely distributed with rounded or elongated nuclei, with a great quantity of myxoid stroma and xanthomatous histiocytes. Recognition of these patterns has proved useful in the histologic identification of schwannomas [2].

Colorectal schwannomas are reported as benign in more than 98% of cases. They are characterized by a low rate of mitosis, the absence of atypical mitotic figures, and nuclear hyperpigmentation. The degree of aggressiveness depends on the Ki-67 index and the mitotic index. Ki-67 index is recommended as an indicator of malignancy. A value of more than 5% correlates with greater tumor aggressiveness and a value of more than 10% is considered malignant [2]. A higher risk of metastasis and/or recurrence has been associated with a mitotic activity rate > 5 mitoses per field at high magnification and a tumor size larger than 5 cm [8]. More than half of the published case reports lacked the complete pathologic description of the schwannoma, and the differentiation between benign and malignant was not based on mitotic index, Ki-67, or MIB-1. Malignant profile was judged based on long-term local and distal recurrence [67, 69, 71]. Metastatic spreading in lymph nodes is exceptional but Das Gupta and Brasfield have reported the occurrence of loco-regional metastases in aggressive tumors (2%) [9]. Three cases of malignant colorectal schwannoma were reported [67, 69, 71] but they lacked data on mitotic activity, Ki-67, and MIB-1. In these case reports, the authors made their conclusion depending on the large size with numerous mitoses [67] and on the emergence of long-term local recurrence and liver metastasis [6971].

The best therapeutic option is complete surgical resection with free negative margins. Radical surgery is not necessary. In reported cases, the observed high frequency of radical resection is due to the absence of accurate preoperative diagnosis. When diagnosed preoperatively, schwannomas were resected either endoscopically or by a wedge resection [35, 56]. According to our research, no patients were offered adjuvant radiotherapy or chemotherapy.

Our review was limited by the small number of published case reports and the low index of pre-operative suspicion which resulted in somewhat hazardous diagnostic examinations. Most patients either did not undergo an abdominal imaging modality or lacked a detailed description of imaging results. Moreover, mitotic index was not calculated in all patients.

Conclusions

In conclusion, schwannoma of the gastrointestinal tract is a rare, usually benign, tumor, and colonic schwannoma is an even more rare occurrence. Differential diagnosis of a submucosal lesion should include schwannoma as well as GIST, NET, and leiomyoma-leiomyosarcoma. Submucosal or deep biopsy might help to make a pre-operative diagnosis. Contrast-enhanced CT scan with low enhancement could help differentiate the well-defined schwannoma from other mesenchymal tumors or adenocarcinoma and exclude distant metastasis in cases of other diagnoses. The definitive diagnosis is based on immunohistochemistry of the operative specimen. Schwannoma stains strongly for S100, and the mitotic index should be calculated to help differentiate benign from malignant lesions. Surgery is the mainstay of treatment, and as for other mesenchymal tumors, wedge resection rather than classic regional resection is advised.

Abbreviations

CEA: 

Carcinoembryonic antigen

CT: 

Computed tomography

EUS: 

Endorectal ultrasound

FDG-PET: 

Fluorodeoxyglucose positron emission tomography

GFAP: 

Glial fibrillary acidic protein

GI: 

Gastrointestinal

GIST: 

Gastrointestinal stromal tumor

NET: 

Neuroendocrine tumor

Declarations

Acknowledgements

We acknowledge a medical writer, Sandy Field, PhD, for editing this manuscript.

Authors’ contributions

All authors are responsible for the conception and design. A Bormans is responsible for the administrative support. A Bohlok, A Bormans, GL, and VD are responsible for the provision of the study materials (articles). MGG, MEK, and MV are responsible for the provision of the study materials (pathology, case report and radiology). A Bohlok, MEK, A Bormans, GL, MV, and MGG are responsible for the collection and assembly of the data. All authors did the data analysis and interpretation. A Bohlok, MEK, and GL did the manuscript writing. All authors read and gave the final approval of the manuscript.

Ethics approval and consent to participate

The patient included in the case provided consent for her data to be used in this publication.

Consent for publication

The patient included in the case provided consent for her data to be used in this publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Surgical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(2)
Institutional Library, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(3)
Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
(4)
Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

References

  1. Tsunoda C, Kato H, Sakamoto T, Yamada R, Mitsumaru A, Yokomizo H, et al. A case of benign schwannoma of the transverse colon with granulation tissue. Case Rep Gastroenterol. 2009;3:116–20. https://doi.org/10.1159/000214837.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Nonose R, Lahan AY, Santos Valenciano J, Martinez CA. Schwannoma of the colon. Case Rep Gastroenterol. 2009;3:293–9. https://doi.org/10.1159/000237736.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Daimaru Y, Kido H, Hashimoto H, Enjoji M. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol. 1988;19:257–64.View ArticlePubMedGoogle Scholar
  4. Miettinen M, Shekitka KM, Sobin LH. Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol. 2001;25:846–55. https://doi.org/10.1097/00000478-200107000-00002.View ArticlePubMedGoogle Scholar
  5. Barbeiro S, Martins C, Gonçalves C, Arroja B, Canhoto M, Silva F, et al. Schwannoma—a rare subepithelial lesion of the colon. GE Port J Gastroenterol. 2015;22:70–4. https://doi.org/10.1016/j.jpge.2015.01.006.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Jung EJ, Han HS, Koh YC, Cho J, Ryu CG, Paik JH, et al. Metachronous schwannoma in the colon with vestibular schwannoma. Ann Surg Treat Res. 2014;87:161–5. https://doi.org/10.4174/astr.2014.87.3.161.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Park KJ, Kim KH, Roh YH, Kim SH, Lee JH, Rha SH, et al. Isolated primary schwannoma arising on the colon: report of two cases and review of the literature. J Korean Surg Soc. 2011;80:367–72. https://doi.org/10.4174/jkss.2011.80.5.367.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Hornick JL, Bundock EA, Fletcher CDM. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors. Am J Surg Pathol. 2009;33:1554–61. https://doi.org/10.1097/PAS.0b013e3181accc6c.View ArticlePubMedGoogle Scholar
  9. Akgul E, Inal M, Soyupak SK, et al. Benign rectal schwannoma. Eur J Radiol Extra. 2003;45:67–70. https://doi.org/10.1016/S1571-4675(03)00007-5.View ArticleGoogle Scholar
  10. Wang WB, Chen WB, Lin JJ, Xu JH, Wang JH, Sheng QS. Schwannoma of the colon: a case report and review of the literature. Oncol Lett. 2016;11:2580–2. https://doi.org/10.3892/ol.2016.4271.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Tashiro Y, Matsumoto F, Iwama K, Shimazu A, Matsumori S, Nohara S, et al. Laparoscopic resection of schwannoma of the ascending colon. Case Rep Gastroenterol. 2015;9:15–9. https://doi.org/10.1159/000373882.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Suzuki T, Suwa K, Hada T, Okamoto T, Fujita T, Yanaga K. Local excision of rectal schwannoma using transanal endoscopic microsurgery: a case report. Int J Surg Case Rep. 2014;5:1193–6. https://doi.org/10.1016/j.ijscr.2014.11.020.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Bugiantella W, Rondelli F, Mariani L, Peppoloni L, Cristallini E, Mariani E. Schwannoma of the colon: a case report. Oncol Lett. 2014;8:2511–2. https://doi.org/10.3892/ol.2014.2545.View ArticlePubMedPubMed CentralGoogle Scholar
  14. De Mesquita Neto JB, Lima Verde Leal RM, De Brito EV, Cordeiro DF, Costa ML. Solitary schwannoma of the cecum: case report and review of the literature. Case Rep Oncol. 2013;6:62–5. https://doi.org/10.1159/000346785.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Vasilakaki T, Skafida E, Arkoumani E, Grammatoglou X, Tsavari KK, Myoteri D, et al. Synchronous primary adenocarcinoma and ancient schwannoma in the colon: an unusual case report. Case Rep Oncol. 2012;5:164–8. https://doi.org/10.1159/000337689.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Kanneganti K, Patel H, Niazi M, Kumbum K, Balar B. Cecal schwannoma: a rare cause of gastrointestinal bleeding in a young woman with review of literature. Gastroenterol Res Pract. 2011:142781. https://doi.org/10.1155/2011/142781.
  17. Goh BKP, Chow PKH, Kesavan S, Yap WM, Ong HS, Song IC, et al. Intraabdominal schwannomas: a single institution experience. J Gastrointest Surg. 2008;12:756–60. https://doi.org/10.1007/s11605-007-0441-3.View ArticlePubMedGoogle Scholar
  18. Inagawa S, Hori M, Shimazaki J, Matsumoto S, Ishii H, Itabashi M, et al. Solitary schwannoma of the colon: report of two cases. Surg Today. 2001;31:833–8. https://doi.org/10.1007/s005950170060.View ArticlePubMedGoogle Scholar
  19. Turaihi H, Assam JH, Sorrell M. Ascending colon schwannoma an unusual cause of acute lower gastrointestinal bleeding. S D Med. 2017;70:33–7. PMID: 28810100PubMedGoogle Scholar
  20. Uhr A, Singh AP, Munoz J, Aka A, Sion M, Jiang W, et al. Colonic schwannoma: a case study and literature review of a rare entity and diagnostic dilemma. Am Surg. 2016;82:1183–6. PMID: 28234182PubMedGoogle Scholar
  21. Meeks MW, Grace S, Chen Y, Petterchak J, Bolesta E, Zhou Y, et al. Synchronous quadruple primary neoplasms: colon adenocarcinoma, collision tumor of neuroendocrine tumor and Schwann cell hamartoma and sessile serrated adenoma of the appendix. Anticancer Res. 2016;36:4307–11. PMID: 27466549PubMedGoogle Scholar
  22. Terada T. Schwannoma and leiomyoma of the colon in a patient with ulcerative colitis. J Gastrointest Cancer. 2016;47:328–30. https://doi.org/10.1007/s12029-015-9747-7.View ArticlePubMedGoogle Scholar
  23. Çakır T, Aslaner A, Yaz M, Ur G. Schwannoma of the sigmoid colon. BMJ Case Rep. 2015; https://doi.org/10.1136/bcr-2014-208934.
  24. Dickson-Lowe RA, James CL, Bailey CM, Abdulaal Y. Caecal schwannoma: a rare cause of per rectal bleeding in a 72-year-old man. BMJ Case Rep. 2014; https://doi.org/10.1136/bcr-2014-205643.
  25. Tokuhara K, Nakatani K, Oishi M, Iwamoto S, Inoue K, Kwon AH. Laparoscopic reduced port surgery for schwannoma of the sigmoid colon: a case report. Asian J Endosc Surg. 2014;7:260–3. https://doi.org/10.1111/ases.12102.View ArticlePubMedGoogle Scholar
  26. Baskaran V, Cho WS, Perry M. Rectal schwannoma on endoscopic polypectomy. BMJ Case Rep. 2014; https://doi.org/10.1136/bcr-2013-010483.
  27. Verdú-Fernández MÁ, Guillén-Paredes MP, García-García ML, García-Marín JA, Pellicer-Franco E, Aguayo-Albasini JL. Schwannoma in descending colon: presentation of a neoplasm in a rare location. Rev Esp Enferm Dig. 2013;105:502–3. PMID: 24274453View ArticlePubMedGoogle Scholar
  28. Baek SJ, Hwangbo W, Kim J, Kim IS. A case of benign schwannoma of the ascending colon treated with laparoscopic-assisted wedge resection. Int Surg. 2013;98:315–8. https://doi.org/10.9738/INTSURG-D-13-00015.1.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Petrie BA, Ho JM, Tolan AM. Schwannoma of the sigmoid colon: a rare cause of sigmoidorectal intussusception. ANZ J Surg. 2014;84:990–1. https://doi.org/10.1111/ans.12364.View ArticlePubMedGoogle Scholar
  30. Shelat VG, Li K, Naik S, Ng CY, Rao N, Rao J, et al. Abdominal schwannomas: case report with literature review. Int Surg. 2013;98:214–8. https://doi.org/10.9738/INTSURG-D-13-00019.1.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Trivedi A, Ligato S. Microcystic/reticular schwannoma of the proximal sigmoid colon: case report with review of literature. Arch Pathol Lab. 2013;137:284–8. https://doi.org/10.5858/arpa.2011-0386-CR.View ArticleGoogle Scholar
  32. Kawaguchi S, Yamamoto R, Yamamura M, Oyamada J, Sato H, Fuke H, et al. Plexiform schwannoma of the rectum. Dig Endosc. 2014;26:113–6. https://doi.org/10.1111/den.12022.View ArticlePubMedGoogle Scholar
  33. Tan AC, Tan CH, Ng CY. Multimodality imaging features of rectal schwannoma. Ann Acad Med Singap. 2012;41:476–8. PMID: 23138147PubMedGoogle Scholar
  34. Yang X, Zeng Y, Wang J. Hybrid schwannoma/perineurioma: report of 10 Chinese cases supporting a distinctive entity. Int J Surg Pathol. 2013;21:22–8. https://doi.org/10.1177/1066896912454566.View ArticlePubMedGoogle Scholar
  35. Matsumoto T, Yamamoto S, Fujita S, Akasu T, Moriya Y. Cecal schwannoma with laparoscopic wedge resection: report of a case. Asian J Endosc Surg. 2011;4:178–80. https://doi.org/10.1111/j.1758-5910.2011.00089.x.View ArticlePubMedGoogle Scholar
  36. Kim HJ, Kim CH, Lim SW, Huh JW, Kim YJ, Kim HR. Schwannoma of ascending colon treated by laparoscopic right hemicolectomy. World J Surg Oncol. 2012;10:81. https://doi.org/10.1186/1477-7819-10-81.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Vijayasekaran A, Tsikitis VL, Gardetto JS, Bracamonte ER, Cohen AM. Rectal schwannoma (neurilemmoma). Am Surg. 2012;78:84–5. PMID: 22369805PubMedGoogle Scholar
  38. Wu YC, Hsieh TC, Kao CH, Yen KY, Sun SS. Simultaneous rectal schwannoma and prostatic adenocarcinoma detected on FDG PET/CT. Clin Nucl Med. 2011;36:948–9. https://doi.org/10.1097/RLU.0b013e31821a2864.View ArticlePubMedGoogle Scholar
  39. Tedeschi M, Cuccia F, Angarano E, Piscitelli D, Gigante G, Altomare DF. Solitary schwannoma of the rectum mimicking rectal cancer. Report of a case and review of the literature. Ann Ital Chir. 2011;82:309–12. PMID: 21834483PubMedGoogle Scholar
  40. Tanaka T, Ishihara Y, Takabayashi N, Kobayashi R, Hiramatsu T, Kuriki K. Gastrointestinal: asymptomatic colonic schwannoma in an elderly woman; a rare case. J Gastroenterol Hepatol. 2011;26:1339. https://doi.org/10.1111/j.1440-1746.2011.06677.x.View ArticlePubMedGoogle Scholar
  41. Rocco EG, Iannuzzi F, Dell'Era A, Falleni M, Moneghini L, Di Nuovo F, et al. Schwann cell hamartoma: case report. BMC Gastroenterol. 2011;11:68. https://doi.org/10.1186/1471-230X-11-68.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Wani HU, Al Omair A, Al Shakweer W, Ahmed B. Schwannoma of the ascending colon with ileocolic intussusception. Trop Gastroenterol. 2010;31:337–9. PMID: 21568158PubMedGoogle Scholar
  43. Kienemund J, Liegl B, Siebert F, Jagoditsch M, Spuller E, Langner C. Microcystic reticular schwannoma of the colon. Endoscopy. 2010;42(Suppl 2):E247. https://doi.org/10.1055/s-0030-1255606.View ArticlePubMedGoogle Scholar
  44. Hsu KF, Lin CT, Wu CC, Hsiao CW, Lee TY, Mai CM, et al. Schwannoma of the rectum: report of a case and review of the literature. Rev Esp Enferm Dig. 2010;102:289–91. PMID: 20486757View ArticlePubMedGoogle Scholar
  45. Wilde BK, Senger JL, Kanthan R. Gastrointestinal schwannoma: an unusual colonic lesion mimicking adenocarcinoma. Can J Gastroenterol. 2010;24:233–6. PMID: 20431810View ArticlePubMedPubMed CentralGoogle Scholar
  46. Mysorekar VV, Rao SG, Jalihal U, Sridhar M. Schwannoma of the ascending colon. Indian J Pathol Microbiol. 2010;53:198–200. https://doi.org/10.4103/0377-4929.59241.View ArticlePubMedGoogle Scholar
  47. Lee SM, Goldblum J, Kim KM. Microcystic/reticular schwannoma in the colon. Pathology. 2009;41:595–6. PMID: 19900114 View ArticlePubMedGoogle Scholar
  48. Chetty R, Vajpeyi R, Penwick JL. Psammomatous melanotic schwannoma presenting as colonic polyps. Virchows Arch. 2007;451:717–20. PMID: 17622556View ArticlePubMedGoogle Scholar
  49. Braumann C, Guenther N, Menenakos C, Junghans T. Schwannoma of the colon mimicking carcinoma: a case report and literature review. Int J Color Dis. 2007;22:1547–8. https://doi.org/10.1007/s00384-006-0264-9.View ArticleGoogle Scholar
  50. Zippi M, Pica R, Scialpi R, Cassieri C, Avallone EV, Occhigrossi G. Schwannoma of the rectum: a case report and literature review. World J Clin Cases. 2013;1:49–51. https://doi.org/10.12998/wjcc.v1.i1.49.View ArticlePubMedPubMed CentralGoogle Scholar
  51. Hsu CT, Hartendorp P, Turi GK, Pollack B, Babich JP, Gusten W, et al. Radiology-pathology conference: colonic schwannoma. Clin Imaging. 2007;31:23–6. PMID: 17189842View ArticlePubMedGoogle Scholar
  52. Emanuel P, Pertsemlidis DS, Gordon R, Xu R. Benign hybrid perineurioma-schwannoma in the colon. A case report. Ann Diagn Pathol. 2006;10:367–70. PMID: 17126257View ArticlePubMedGoogle Scholar
  53. Fotiadis CI, Kouerinis IA, Papandreou I, Zografos GC, Agapitos G. Sigmoid schwannoma: a rare case. World J Gastroenterol. 2005;11:5079–81. PMID: 16124072View ArticlePubMedPubMed CentralGoogle Scholar
  54. Bhardwaj K, Bal MS, Kumar P. Rectal schwannoma. Indian J Gastroenterol. 2002;21:116–7. PMID: 12118926PubMedGoogle Scholar
  55. Jacobson BC, Hirsch MS, Lee JH, Van Dam J, Shoji B, Farraye FA. Multiple asymptomatic plexiform schwannomas of the sigmoid colon: a case report and review. Gastrointest Endosc. 2001;53:801–4. PubMed PMID: 11375596View ArticlePubMedGoogle Scholar
  56. Maciejewski A, Lange D, Włoch J. Case report of schwannoma of the rectum—clinical and pathological contribution. Med Sci Monit. 2000;6:779–82.PubMedGoogle Scholar
  57. Matsushita M, Hajiro K, Takakuwa H, Nishio A. Endoscopic removal of colonic neurinoma arising from the submucosa. Am J Gastroenterol. 2000;95:3001–2. 11051399View ArticlePubMedGoogle Scholar
  58. Horio Y, Watanabe F, Shirakawa K, Kageoka M, Iwasaki H, Maruyama Y, et al. Schwannoma of the sigmoid colon. Gastrointest Endosc. 2000;52:528. PMID: 11023574View ArticlePubMedGoogle Scholar
  59. Sasatomi T, Tsuji Y, Tanaka T, Horiuchi H, Hyodo S, Takeuchi K, et al. Schwannoma in the sigmoid colon: report of a case. Kurume Med J. 2000;47:165–8. PMID: 10948655View ArticlePubMedGoogle Scholar
  60. Prévot S, Bienvenu L, Vaillant JC, de Saint-Maur PP. Benign schwannoma of the digestive tract: a clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am J Surg Pathol. 1999;23:431–6. 10199472View ArticlePubMedGoogle Scholar
  61. Tomozawa S, Masaki T, Matsuda K, Yokoyama T, Ishida T, Muto T. A schwannoma of the cecum: case report and review of Japanese schwannomas in the large intestine. J Gastroenterol. 1998;33:872–5. 9853563View ArticlePubMedGoogle Scholar
  62. Skopelitou AS, Mylonakis EP, Charchanti AV, Kappas AM. Cellular neurilemoma (schwannoma) of the descending colon mimicking carcinoma: report of a case. Dis Colon Rectum. 1998;41:1193–6. 9749505View ArticlePubMedGoogle Scholar
  63. Kakizoe S, Kuwahara S, Kakizoe K, Kakizoe H, Kakizoe Y, Kakizoe T, et al. Local excision of benign rectal schwannoma using rectal expander-assisted transanal endoscopic microsurgery. Gastrointest Endosc. 1998;48:90–2. 9684677View ArticlePubMedGoogle Scholar
  64. Murakami N, Tanaka T, Ohmori Y, Shirouzu Y, Ishibashi S, Harada Y, et al. A case report of rectal schwannoma. Kurume Med J. 1996;43:101–6. PMID: 8709552View ArticlePubMedGoogle Scholar
  65. Sugimura H, Tamura S, Yamada H, Kusumoto S, Watanabe K, Hayashi T, et al. Benign nerve sheath tumor of the sigmoid colon. Clin Imaging. 1993;17:64–6. 8439849View ArticlePubMedGoogle Scholar
  66. Abel ME, Nehme Kingsley AE, Abcarian H, Arlenga P, Barron SS. Anorectal neurilemomas. Dis Colon Rectum. 1985;28:960–1. 4064859View ArticlePubMedGoogle Scholar
  67. Schwartz DA. Malignant schwannoma occurring with Schistosoma japonicum: a case report. Southeast Asian J Trop Med Public Health. 1983;13:601–5. 7170642Google Scholar
  68. Cleveland BR, Cunningham PJ. Giant neurilemmoma of the transverse mesocolon. Case report Am Surg. 1966;32:461–3. 5938620PubMedGoogle Scholar
  69. Bodner E, De los Santos EV. The malignant degeneration of a rectal neurinoma; views on the tendency of the tumors of the nerve sheaths towards malignant degeneration. Philipp J Surg Surg Spec. 1965;20:125–41. PMID: 5896930PubMedGoogle Scholar
  70. Wang CL, Neville AM, Wong TZ, Hall AH, Paulson EK, Bentley RC. Colonic schwannoma visualized on FDG PET/CT. Clin Nucl Med. 2010;35:181–3. https://doi.org/10.1097/RLU.0b013e3181cc632a.View ArticlePubMedGoogle Scholar
  71. Catania G, Puleo C, Cardì F, et al. Malignant schwannoma of the rectum: a clinical and pathological contribution. Chir Ital. 2011;53:873–7. 11824066Google Scholar
  72. Levy AD, Quiles AM, Miettinen M, Sobin LH. Gastrointestinal schwannomas: CT features with clinicopathologic correlation. AJR Am J Roentgenol. 2005;184:797–802. https://doi.org/10.2214/ajr.184.3.01840797.View ArticlePubMedGoogle Scholar
  73. Das Gupta TK, Brasfield RD. Tumors of peripheral nerve origin: benign and malignant solitary schwannomas. CA Cancer J Clin. 1970;20:228–33. 4316984View ArticlePubMedGoogle Scholar
  74. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10:81–9. https://doi.org/10.1177/106689690201000201.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement